A POC and Dose-Ranging Study of HTD1801 in PSC Patients

Clinical trial NCT03333928 · COMPLETED

Trial details

NCT number: NCT03333928
Sponsor: HighTide Biopharma Pty Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis (PSC)

Start date: 2018-02-09
Primary completion: 2020-04-30
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.